DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
Schuler PJ, Harasymczuk M, Visus C. et al.
Phase I dendritic cell p53 peptide vaccine for head and neck cancer.
Clinical cancer research: an official journal of the American Association for Cancer Research 2014;
20: 2433-2444
We do not assume any responsibility for the contents of the web pages of other providers.